Close Menu

NEW YORK – SomaLogic said on Thursday that it has launched a collaboration with Amgen to use its SomaScan proteomics platform within Amgen's drug discovery and development programs.

Under the agreement, SomaLogic will analyze more than 40,000 samples, including from Amgen clinical trials.

The deal builds on a 2018 agreement between SomaLogic and Amgen subsidiary Decode Genetics that called for Somalogic to analyze up to 40,000 of Decode's patient samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.

Sep
09
Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.